MobiHealth News June 22, 2021
Laura Lovett

The company said the deal could help it with commercialization and expansion.

Digital therapeutic company Pear announced its plans to go public via a $1.6 billion special purpose acquisition company (SPAC) merger with Thimble Point Acquisition Corp.

The new combined company will be called Pear Holdings Corp and traded on Nasdaq. Pear leadership will continue to head up the new combined entity. According to the companies, the combined business includes up to $276 million in funds located in Thimble Point’s trust account, as well as $125 million in private investment in public equity.

In 2017, Pear’s substance abuse disorder prescription digital therapeutic (PDT) ReSET made headlines when it landed an FDA de novo. Since then the company has cleared two...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Pharma, Pharma / Biotech, Trends
Pharma Pulse 4/23/24: Drug Discount Programs Poised to Change with New Tech, SpecialtyRx Savings Navigator to Enhance Affordability & more
AI Ushers in HPC Revival Says TACC’s Dan Stanzione
Ozempic And Other Weight Loss Drugs Will Only Work With Digital Health
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Bristol Myers taps startup to boost cell therapy production

Share This Article